Amgen v. Sanofi: Critical Impact on the Value of Innovative Science in Antibody Discovery

Joseph P. Balthasar

doi:10.1208/s12248-023-00816-3

Amgen v. Sanofi: Critical Impact on the Value of Innovative Science in Antibody Discovery

Joseph P. Balthasar

Pharmaceutical Sciences

Research output: Contribution to journal › Comment/debate

Original language	English
Article number	51
Journal	AAPS PharmSci
Volume	25
Issue number	3
DOIs	https://doi.org/10.1208/s12248-023-00816-3
State	Published - May 2023

Keywords

Antibody
Discovery
Monoclonal Antibody
Patent

Access to Document

10.1208/s12248-023-00816-3

Cite this

@article{0faede20f1404fd584122773b77b4b5e,

title = "Amgen v. Sanofi: Critical Impact on the Value of Innovative Science in Antibody Discovery",

keywords = "Antibody, Discovery, Monoclonal Antibody, Patent",

author = "Balthasar, \{Joseph P.\}",

year = "2023",

month = may,

doi = "10.1208/s12248-023-00816-3",

language = "English",

volume = "25",

journal = "AAPS PharmSci",

issn = "1522-1059",

publisher = "AAPS PharmSci Editorial Office",

number = "3",

}

TY - JOUR

T1 - Amgen v. Sanofi

T2 - Critical Impact on the Value of Innovative Science in Antibody Discovery

AU - Balthasar, Joseph P.

PY - 2023/5

Y1 - 2023/5

KW - Antibody

KW - Discovery

KW - Monoclonal Antibody

KW - Patent

UR - https://www.scopus.com/pages/publications/85159740111

U2 - 10.1208/s12248-023-00816-3

DO - 10.1208/s12248-023-00816-3

M3 - Comment/debate

C2 - 37173551

AN - SCOPUS:85159740111

SN - 1522-1059

VL - 25

JO - AAPS PharmSci

JF - AAPS PharmSci

IS - 3

M1 - 51

ER -

Amgen v. Sanofi: Critical Impact on the Value of Innovative Science in Antibody Discovery

Keywords

Access to Document

Other files and links

Fingerprint

Cite this